An interventional study of Face mask with hybrid-hyrax and Face mask with conventional bonded RME in Anterior Crossbite, Class III Malocclusion and Maxillary Deficiency, sponsored by Izmir Katip Celebi University. Status unknown at 1 site in Turkey. Open to participants aged 10 Years to 13 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-04-28.
Sponsored by Izmir Katip Celebi University · Not applicable, Interventional, and Treatment
The aim of this prospective randomized controlled clinical study is to compare the effects of bone-anchored and tooth borne maxillary protraction on dentofacial structures in skeletal Class III patients.
Today, the treatment of class III malocclusion is becoming more important due to the increased awareness of people about their appearance and the impact of appearance on the psychosocial state.
Various studies have shown that 40% of class III malocclusions are clinically caused by maxillary deficiency, 42% by mandibular excess, and 18% by a combination of maxillary deficiency and mandibular excess.
The face mask is the most effective treatment modality for class III malocclusions caused by a maxillary deficiency. The rationale for using a face mask is to apply heavy forces to the midface to advance the maxilla forward. These forces cause disarticulation by initiating resorption and apposition in the sutural articulations. However, undesirable dental effects arise from the use of tooth-borne rapid maxillary expansion (RME) during these treatments. These include loss of anchorage and incisor proclination during the mesialization of the maxillary dentition, extrusion of the upper molars and posterior mandibular rotation, and insufficient anterior displacement of the maxilla (1-3 mm).
Studies have shown that increasing the skeletal effects can reduce post-treatment relapse, one of the most important problems in orthodontics.
To increase the amount of maxillary skeletal advancement and to minimize the side effects of tooth-borne maxillary expansion and protraction, a new bone-anchored hybrid hyrax appliance has been proposed. Hybrid hyrax treatment has the following advantages over tooth-borne mechanics:
57 studies on the registry are indexed under Malocclusion, Angle Class III; 11 are open to participants now.
This study's planned enrollment of 42 is above the median of 32 across 53 interventional studies indexed under Malocclusion, Angle Class III.
Browse Malocclusion, Angle Class III studies →Izmir Katip Celebi University is the lead sponsor of 198 studies on the registry; 39 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Face mask with hybrid-hyrax
Other: Face mask with hybrid-hyrax
Face mask with conventional bonded RME
Other: Face mask with conventional bonded RME
Control group consisting of 14 non-treated Class III malocclusion subjects
Face mask with hybrid-hyrax
Face mask with conventional bonded RME
Pre-treatment (T0) cephalometric analysis measures
A cephalometric analysis of skeletal maxillary (SNA) and mandibular (SNB) positions
Time frame: 0 month
Pre-treatment (T0) soft tissues measurements
Maxillary and mandibular (Soft tissue convexity angle) soft tissue analysis using 3D stereophotogrammetry
Time frame: 0 month
Post-treatment (T1) cephalometric analysis measurements
Evaluation of pos-treatment cephalometric changes of skeletal maxillary (SNA) and mandibular (SNB) positions
Time frame: An average of 6 month
Post-treatment (T1) soft tissues measurements
Evaluation of maxillary and mandibular soft tissue changes (Soft tissue convexity angle) using 3D stereophotogrammetry
Time frame: An average of 6 month
This study is status unknown, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Malocclusion, Angle Class III →
Izmir Katip Celebi University →